Atomoxetine and DAW2022 on OSA Severity

Clinical trial NCT05350215 · RECRUITING

Trial details

NCT number: NCT05350215
Sponsor: Brigham and Women's Hospital
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Obstructive Sleep Apnea

Start date: 2022-06-01
Primary completion: 2026-12-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.